<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-30T14:37:38Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/6825" metadataPrefix="marc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/6825</identifier><datestamp>2026-02-06T12:50:50Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4365</setSpec><setSpec>col_10259_4364</setSpec><setSpec>col_10259_4366</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Rubio Antolin, Ana Rosa</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">González, Rocío</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Busto Vázquez, Natalia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Vaquero Gutiérrez, Mónica</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Iglesias, Ana L.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Jalón Sotés, Félix Ángel</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Espino Ordóñez, Gustavo</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Rodríguez, Ana M.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">García Ruiz, Begoña</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Manzano, Blanca R. .</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2021-09</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">An important challenge in the field of anticancer chemotherapy is the search for new species&#xd;
to overcome the resistance of standard drugs. An interesting approach is to link bioactive ligands to&#xd;
metal fragments. In this work, we have synthesized a set of p-cymene-Ru or cyclopentadienyl-M&#xd;
(M = Rh, Ir) complexes with four chrysin-derived pro-ligands with different -OR substituents at&#xd;
position 7 of ring A. The introduction of a piperidine ring on chrysin led to the highly cytotoxic&#xd;
pro-ligand HL4 and its metal complexes L4-M (SW480 and A549 cell lines, cytotoxic order: L4-Ir >&#xd;
L4-Ru ≈ L4-Rh). HL4 and its complexes induce apoptosis and can overcome cis-platinum resistance.&#xd;
However, HL4 turns out to be more cytotoxic in healthy than in tumor cells in contrast to its metal&#xd;
complexes which displayed higher selectivity than cisplatin towards cancer cells. All L4-M complexes&#xd;
interact with double stranded DNA. Nonetheless, the influence of the metal is clear because only&#xd;
complex L4-Ir causes DNA cleavage, through the generation of highly reactive oxygen species (1O2&#xd;
).&#xd;
This result supports the hypothesis of a potential dual mechanism consisting of two different chemical&#xd;
pathways: DNA binding and ROS generation. This behavior provides this complex with a great&#xd;
effectivity in terms of cytotoxicity</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">1999-4923</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">http://hdl.handle.net/10259/6825</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.3390/pharmaceutics13101540</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">1999-4923</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Chrysin ligands</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Iridium</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Ruthenium</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Rhodium</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Cancer</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Metallodrugs</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Piperidine</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Half-sandwich</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>